Carboxypeptidase vitellogenic like facilitates resistance to CDK4/6 inhibitors in breast cancer.
Thoracic cancer（2023）
摘要
CPVL might be a key factor in regulating breast cancer resistance to CDK4/6 inhibitors.
更多查看译文
关键词
CDK4/6 inhibitor,CPVL,breast cancer,resistance
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要